BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8663103)

  • 1. Alterations in calcium channel currents underlie defective insulin secretion in a transgenic mouse.
    Jan CR; Ribar TJ; Means AR; Augustine GJ
    J Biol Chem; 1996 Jun; 271(26):15478-85. PubMed ID: 8663103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective glycolysis and calcium signaling underlie impaired insulin secretion in a transgenic mouse.
    Ribar TJ; Jan CR; Augustine GJ; Means AR
    J Biol Chem; 1995 Dec; 270(48):28688-95. PubMed ID: 7499389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
    Sato Y; Anello M; Henquin JC
    Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted overexpression of an inactive calmodulin that binds Ca2+ to the mouse pancreatic beta-cell results in impaired secretion and chronic hyperglycemia.
    Ribar TJ; Epstein PN; Overbeek PA; Means AR
    Endocrinology; 1995 Jan; 136(1):106-15. PubMed ID: 7828519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon induces suppression of ATP-sensitive K+ channel activity through a Ca2+/calmodulin-dependent pathway in mouse pancreatic beta-cells.
    He LP; Mears D; Atwater I; Kitasato H
    J Membr Biol; 1998 Dec; 166(3):237-44. PubMed ID: 9843597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.
    Anello M; Gilon P; Henquin JC
    Br J Pharmacol; 1999 Aug; 127(8):1883-91. PubMed ID: 10482920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of calmodulin in glucagon-like peptide 1(7-36) amide-induced inhibition of the ATP-sensitive K+ channel in mouse pancreatic beta-cells.
    Ding WG; Kitasato H; Matsuura H
    Exp Physiol; 2001 May; 86(3):331-9. PubMed ID: 11429650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells.
    Mariot P; Gilon P; Nenquin M; Henquin JC
    Diabetes; 1998 Mar; 47(3):365-73. PubMed ID: 9519741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinism of infancy: the regulated release of insulin by KATP channel-independent pathways.
    Straub SG; Cosgrove KE; Ammälä C; Shepherd RM; O'Brien RE; Barnes PD; Kuchinski N; Chapman JC; Schaeppi M; Glaser B; Lindley KJ; Sharp GW; Aynsley-Green A; Dunne MJ
    Diabetes; 2001 Feb; 50(2):329-39. PubMed ID: 11272144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose controls cytosolic Ca2+ and insulin secretion in mouse islets lacking adenosine triphosphate-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.
    Ravier MA; Nenquin M; Miki T; Seino S; Henquin JC
    Endocrinology; 2009 Jan; 150(1):33-45. PubMed ID: 18787024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of caffeine on cytoplasmic free Ca2+ concentration in pancreatic beta-cells are mediated by interaction with ATP-sensitive K+ channels and L-type voltage-gated Ca2+ channels but not the ryanodine receptor.
    Islam MS; Larsson O; Nilsson T; Berggren PO
    Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):679-86. PubMed ID: 7702559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between cytoplasmic Ca2+ and the ATP/ADP ratio: a feedback control mechanism in mouse pancreatic islets.
    Detimary P; Gilon P; Henquin JC
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):269-74. PubMed ID: 9657965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triggering and amplifying pathways of regulation of insulin secretion by glucose.
    Henquin JC
    Diabetes; 2000 Nov; 49(11):1751-60. PubMed ID: 11078440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both triggering and amplifying pathways contribute to fuel-induced insulin secretion in the absence of sulfonylurea receptor-1 in pancreatic beta-cells.
    Nenquin M; Szollosi A; Aguilar-Bryan L; Bryan J; Henquin JC
    J Biol Chem; 2004 Jul; 279(31):32316-24. PubMed ID: 15175349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct interference of HIV protease inhibitors with pancreatic beta-cell function.
    Düfer M; Neye Y; Krippeit-Drews P; Drews G
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):583-90. PubMed ID: 15197535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin secretion and intracellular Ca2+ rises in monolayer cultures of neonatal rat beta-cells.
    Black MA; Mealing GA; Whitfield JF; Schwartz JL; Bégin-Heick N
    Cell Signal; 1994 Nov; 6(8):897-904. PubMed ID: 7718409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil, a phenylalkylamine Ca2+ channel blocker, inhibits ATP-sensitive K+ channels in insulin-secreting cells from rats.
    Lebrun P; Antoine MH; Ouedraogo R; Pirotte B; Herchuelz A; Cosgrove KE; Kane C; Dunne MJ
    Diabetologia; 1997 Dec; 40(12):1403-10. PubMed ID: 9447947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
    Chapman JC; McClenaghan NH; Cosgrove KE; Hashmi MN; Shepherd RM; Giesberts AN; White SJ; Ammälä C; Flatt PR; Dunne MJ
    Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of glucose to elicit a normal secretory response in fetal pancreatic beta cells results from glucose insensitivity of the ATP-regulated K+ channels.
    Rorsman P; Arkhammar P; Bokvist K; Hellerström C; Nilsson T; Welsh M; Welsh N; Berggren PO
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4505-9. PubMed ID: 2543980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.
    Garcia-Barrado MJ; Jonas JC; Gilon P; Henquin JC
    Eur J Pharmacol; 1996 Mar; 298(3):279-86. PubMed ID: 8846827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.